Get 20% lifetime commission for referring investors to digrin.com
here.
Olema Pharmaceuticals, Inc. ( OLMA) - Key Metrics
OLMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.61 | -$0.44 | -$0.44 |
| 2026Q1 | $0 | -$0.52 | -$0.45 | -$0.45 |
| 2025Q4 | $0 | -$0.50 | -$0.42 | -$0.42 |
| 2025Q3 | $0 | -$0.49 | -$0.40 | -$0.40 |
| 2025Q2 | $0 | -$0.51 | -$0.35 | -$0.35 |
OLMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.13 |
| 2026Q1 | 0% | -7.17 |
| 2025Q4 | 0% | -12.50 |
| 2025Q3 | 0% | -4.99 |
| 2025Q2 | 0% | -2.09 |
OLMA
Price: $6.58
52 week price:
Earnings Per Share: -2.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 106400
Market Capitalization: 693.5 million